Literature DB >> 21855383

Seroprevalence of antibodies to influenza A/H1N1/2009 among transmission risk groups after the second wave in Mexico, by a virus-free ELISA method.

Leticia Elizondo-Montemayor1, Mario M Alvarez, Martín Hernández-Torre, Patricia A Ugalde-Casas, Lorena Lam-Franco, Humberto Bustamante-Careaga, Fernando Castilleja-Leal, Julio Contreras-Castillo, Héctor Moreno-Sánchez, Daniela Tamargo-Barrera, Felipe López-Pacheco, Pamela J Freiden, Stacey Schultz-Cherry.   

Abstract

OBJECTIVE: No serological studies have been performed in Mexico to assess the seroprevalence of influenza A/H1N1/2009 in groups of people according to the potential risk of transmission. The aim of this study was to determine the seroprevalence of antibodies against influenza A/H1N1/2009 in subjects in Mexico grouped by risk of transmission.
METHODS: Two thousand two hundred and twenty-two subjects were categorized into one of five occupation groups according to the potential risk of transmission: (1) students, (2) teachers, (3) healthcare workers, (4) institutional home residents aged >60 years, and (5) general population. Seroprevalence by potential transmission group and by age grouped into decades was determined by a virus-free ELISA method based on the recombinant receptor-binding domain of the hemagglutinin of influenza A/H1N1/2009 virus as antigen (85% sensitivity; 95% specificity). The Wilson score, Chi-square test, and logistic regression models were used for the statistical analyses.
RESULTS: Seroprevalence for students was 47.3%, for teachers was 33.9%, for older adults was 36.5%, and for the general population was 33.0%, however it was only 24.6% for healthcare workers (p=0.011). Of the students, 56.6% of those at middle school, 56.4% of those at high school, 52.7% of those at elementary school, and 31.1% of college students showed positive antibodies (p<0.001). Seroprevalence was 44.6% for college teachers, 31.6% for middle school teachers, and 29.8% for elementary school teachers, but was only 20.3% for high school teachers (p=0.002).
CONCLUSIONS: The student group was the group most affected by influenza A/H1N1/2009, while the healthcare worker group showed the lowest prevalence. Students represent a key target for preventive measures.
Copyright © 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21855383      PMCID: PMC4041370          DOI: 10.1016/j.ijid.2011.07.002

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  29 in total

1.  Assessing the severity of the novel influenza A/H1N1 pandemic.

Authors:  Tini Garske; Judith Legrand; Christl A Donnelly; Helen Ward; Simon Cauchemez; Christophe Fraser; Neil M Ferguson; Azra C Ghani
Journal:  BMJ       Date:  2009-07-14

Review 2.  How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count.

Authors:  Marc Lipsitch; Frederick G Hayden; Benjamin J Cowling; Gabriel M Leung
Journal:  Lancet       Date:  2009-08-11       Impact factor: 79.321

3.  The receptor-binding domain of influenza virus hemagglutinin produced in Escherichia coli folds into its native, immunogenic structure.

Authors:  Rebecca M DuBois; José Manuel Aguilar-Yañez; Gonzalo I Mendoza-Ochoa; Yuriana Oropeza-Almazán; Stacey Schultz-Cherry; Mario Moisés Alvarez; Stephen W White; Charles J Russell
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

Review 4.  2009 H1N1 influenza.

Authors:  Seth J Sullivan; Robert M Jacobson; Walter R Dowdle; Gregory A Poland
Journal:  Mayo Clin Proc       Date:  2009-12-10       Impact factor: 7.616

5.  Specific recognition of influenza A/H1N1/2009 antibodies in human serum: a simple virus-free ELISA method.

Authors:  Mario M Alvarez; Felipe López-Pacheco; José M Aguilar-Yañez; Roberto Portillo-Lara; Gonzalo I Mendoza-Ochoa; Sergio García-Echauri; Pamela Freiden; Stacey Schultz-Cherry; Manuel I Zertuche-Guerra; David Bulnes-Abundis; Johari Salgado-Gallegos; Leticia Elizondo-Montemayor; Martín Hernández-Torre
Journal:  PLoS One       Date:  2010-04-14       Impact factor: 3.240

6.  An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli.

Authors:  José M Aguilar-Yáñez; Roberto Portillo-Lara; Gonzalo I Mendoza-Ochoa; Sergio A García-Echauri; Felipe López-Pacheco; David Bulnes-Abundis; Johari Salgado-Gallegos; Itzel M Lara-Mayorga; Yenny Webb-Vargas; Felipe O León-Angel; Ramón E Rivero-Aranda; Yuriana Oropeza-Almazán; Guillermo M Ruiz-Palacios; Manuel I Zertuche-Guerra; Rebecca M DuBois; Stephen W White; Stacey Schultz-Cherry; Charles J Russell; Mario M Alvarez
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

7.  Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA.

Authors:  Shanta M Zimmer; Corey J Crevar; Donald M Carter; James H Stark; Brendan M Giles; Richard K Zimmerman; Stephen M Ostroff; Bruce Y Lee; Donald S Burke; Ted M Ross
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

Review 8.  Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans.

Authors:  J S Malik Peiris; Leo L M Poon; Yi Guan
Journal:  J Clin Virol       Date:  2009-06-11       Impact factor: 3.168

9.  Seroprevalence of antibodies to pandemic (H1N1) 2009 influenza virus among hospital staff in a medical center in Taiwan.

Authors:  Yu-Jiun Chan; Chia-Ling Lee; Shinn-Jang Hwang; Chang-Phone Fung; Fu-Der Wang; David H T Yen; Cheng-Hsien Tsai; Yi-Ming Arthur Chen; Shou-Dong Lee
Journal:  J Chin Med Assoc       Date:  2010-02       Impact factor: 2.743

10.  Social contacts and mixing patterns relevant to the spread of infectious diseases.

Authors:  Joël Mossong; Niel Hens; Mark Jit; Philippe Beutels; Kari Auranen; Rafael Mikolajczyk; Marco Massari; Stefania Salmaso; Gianpaolo Scalia Tomba; Jacco Wallinga; Janneke Heijne; Malgorzata Sadkowska-Todys; Magdalena Rosinska; W John Edmunds
Journal:  PLoS Med       Date:  2008-03-25       Impact factor: 11.069

View more
  13 in total

1.  WITHDRAWN: Intense Seasonal A/H1N1 Influenza in Mexico, Winter 2013-2014.

Authors:  Javier Dávila-Torres; Gerardo Chowell; Víctor H Borja-Aburto; Cécile Viboud; Concepción Grajalez-Muñiz; Mark A Miller
Journal:  Arch Med Res       Date:  2014-11-20       Impact factor: 2.235

2.  Epidemiological characterization of a fourth wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: age shift and severity.

Authors:  Víctor H Borja-Aburto; Gerardo Chowell; Cécile Viboud; Lone Simonsen; Mark A Miller; Concepción Grajales-Muñiz; Cesar R González-Bonilla; Jose A Diaz-Quiñonez; Santiago Echevarría-Zuno
Journal:  Arch Med Res       Date:  2012-10-16       Impact factor: 2.235

3.  Seroprevalence of influenza A H1N1 (swine) infection in the human population in a cantonment.

Authors:  Arvind Singh Kushwaha; Atul Kotwal; C I Biradar; Mahadevan Kumar; Shailesh D Pawar; Mandeep Chadha; Seema Patrikar
Journal:  Med J Armed Forces India       Date:  2019-06-04

4.  Evaluation of the seroprevalence of influenza A(H1N1) 2009 on a university campus: a cross-sectional study.

Authors:  Shira C Shafir; Kaitlin A O'Keefe; Kimberley I Shoaf
Journal:  BMC Public Health       Date:  2011-12-13       Impact factor: 3.295

5.  Recrudescent wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: Age shift and severity.

Authors:  Gerardo Chowell; Santiago Echevarría-Zuno; Cecile Viboud; Lone Simonsen; Concepcion Grajales Muñiz; Ramón Alberto Rascón Pacheco; Margot González León; Víctor Hugo Borja Aburto
Journal:  PLoS Curr       Date:  2012-02-24

6.  CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.

Authors:  Peter W Horby; Karen L Laurie; Benjamin J Cowling; Othmar G Engelhardt; Katharine Sturm-Ramirez; Jose L Sanchez; Jacqueline M Katz; Timothy M Uyeki; John Wood; Maria D Van Kerkhove
Journal:  Influenza Other Respir Viruses       Date:  2016-08-09       Impact factor: 4.380

7.  Evidence of transmission and risk factors for influenza A virus in household dogs and their owners.

Authors:  Luis A Ramírez-Martínez; María Contreras-Luna; Jazmín De la Luz; María E Manjarrez; Dora P Rosete; José F Rivera-Benitez; Manuel Saavedra-Montañez; Humberto Ramírez-Mendoza
Journal:  Influenza Other Respir Viruses       Date:  2013-08-30       Impact factor: 4.380

8.  Substantial Morbidity and Mortality Associated with Pandemic A/H1N1 Influenza in Mexico, Winter 2013-2014: Gradual Age Shift and Severity.

Authors:  Javier Dávila; Gerardo Chowell; Víctor H Borja-Aburto; Cécile Viboud; Concepciòn Grajales Muñiz; Mark Miller
Journal:  PLoS Curr       Date:  2014-03-26

9.  A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic.

Authors:  Vic Veguilla; Hugo López-Gatell; Irma López-Martínez; Rodrigo Aparicio-Antonio; Gisela Barrera-Badillo; Julieta Rojo-Medina; Felicia Liaini Gross; Stacie N Jefferson; Jacqueline M Katz; Mauricio Hernández-Ávila; Celia M Alpuche-Aranda
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

Review 10.  Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries.

Authors:  Maria D Van Kerkhove; Siddhivinayak Hirve; Artemis Koukounari; Anthony W Mounts
Journal:  Influenza Other Respir Viruses       Date:  2013-01-21       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.